澳大利亚免疫技术咨询小组 (ATAGI) 关于使用 Spikevax (Moderna) 作为 COVID-19 加强疫苗的建议
在最近获得 TGA 的批准后， 澳大利亚免疫技术咨询小组 (ATAGI) 已推荐 使用 Spikevax (Moderna) 作为 COVID-19 加强疫苗，适用于 5 个月或更长时间前完成 COVID-19 疫苗初级课程的 18 岁及以上人群（包括孕妇）。加强剂量是用于初级课程的 Spikevax 疫苗推荐剂量的一半。
ATAGI 指出，Moderna 和辉瑞公司的 COVID-19 疫苗在澳大利亚的合格人群中同样可以用作加强疫苗。
To read ATAGI's 关于使用 Moderna COVID-19 疫苗作为加强剂的完整声明如下 下面的链接:
澳大利亚免疫技术咨询小组 (ATAGI) 关于使用 Spikevax (Moderna) 作为 COVID-19 加强疫苗的建议
Australian Academy of Science: COVID-19 vaccines and their long-term safety
Getting vaccinated against COVID-19 is the best way to protect ourselves and our communities. Current data and evidence confidently support the long term safety of COVID-19 vaccines.
This article discusses the various safety processes currently in place for COVID-19 vaccines to ensure that they continue to be effective in preventing severe disease.
To read the article in full, click on the link below:
COVID-19 vaccines and their long-term safety
New educational resource: Generation Next course on COVID and kids
MVEC has collaborated with the team at Generation Next on a new resource featuring Dr Daryl Cheng to provide helpful strategies to get kids back to school safely and reduce transmission of COVID-19 in this group.
Course content reflects the combined efforts of immunisation paediatricians, adult physicians, immunisation nurses, infectious disease, and allergy specialists, as well as infection control teams. The information works to provide guidance and support for parents and communities to ensure a safe transition to a new COVID normal.
To enrol in this free course, please click on the link below:
Next Generation course: Covid and kids